Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2953–2976 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Pancreatitis, Chronic, Abdominal Pain
Interventions: EUS-celiac ganglia block (EUS-CGB), EUS-celiac plexus block (EUS-CPB); Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Bipolar Depression
Interventions: Deep TMS Treatment, Sham Treatment; Device
Lead sponsor: Brainsway; Industry
Eligibility: 22 Years to 68 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 9
States / cities: Juno Beach, Florida • Palm Beach, Florida • Royal Palm Beach, Florida + 6 more

Conditions: Caregiver, Malignant Head and Neck Neoplasm, Paranasal Sinus Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell Carcinoma, Stage II Hypopharyngeal Squamous Cell Carcinoma, Stage II Laryngeal Squamous Cell Carcinoma, Stage II Lip and Oral Cavity Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma, Stage III Laryngeal Squamous Cell Carcinoma, Stage III Lip and Oral Cavity Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma, Stage IV Hypopharyngeal Squamous Cell Carcinoma, Stage IV Laryngeal Squamous Cell Carcinoma, Stage IV Lip and Oral Cavity Squamous Cell Carcinoma, Stage IV Oropharyngeal Squamous Cell Carcinoma, Stage IVA Hypopharyngeal Squamous Cell Carcinoma, Stage IVA Laryngeal Squamous Cell Carcinoma, Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Hypopharyngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Squamous Cell Carcinoma, Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVB Oropharyngeal Squamous Cell Carcinoma, Stage IVC Hypopharyngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Squamous Cell Carcinoma, Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVC Oropharyngeal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Lip and Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal SCC, Recurrent Paranasal Sinus Squamous Cell Carcinoma
Interventions: Communication Intervention, Watch video, Module completion of the Prepare to Care kit, Quality-of-Life Assessment, Survey Administration, Salivary cortisol collection; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Asthma
Interventions: NIPPV (PALMtop PTV), Volumetric CO2 (NM3), USCOM; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 2 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Opioid Use Disorder
Interventions: buprenorphine-naloxone; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Incontinence-associated Dermatitis, Decubitus Ulcer
Interventions: Dynamic Oxygen Skin Therapy (DOST), Standard Wound Care; Device · Other
Lead sponsor: RashEndZ Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Pregnancy Related, Labor, Induction, Cervical Ripening
Interventions: Inpatient Foley catheter, Outpatient Foley catheter; Other
Lead sponsor: LifeBridge Health; Other
Eligibility: 14 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Baltimore, Maryland • Philadelphia, Pennsylvania

Conditions: Renal Transplantation, Mesenchymal Stem Cells
Interventions: Mesenchymal Stromal Stem Cells (MSCs) Infusion, Normal Saline (Placebo) Infusion; Biological · Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Total Knee Replacement, Postoperative Pain
Interventions: Bupivacaine HCl, F14 (celecoxib); Drug
Lead sponsor: Arthritis Innovation Corporation; Industry
Eligibility: 45 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Denver, Colorado • Dayton, Ohio • San Antonio, Texas

Conditions: HIV Infection, Sexually Transmitted Infection
Interventions: HIV PrEP - choice of F/TDF, F/TAF, or CAB-LA, STI PEP - Doxycycline as Doxy-PEP, 3P mHealth package, Handout about HIV PrEP options available at the site, Standard-of-care HIV PrEP counseling from qualified study staff; Drug · Behavioral
Lead sponsor: HIV Prevention Trials Network; Network
Eligibility: 18 Years to 29 Years · Male only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • The Bronx, New York

Conditions: Vaginal Atrophy, Vaginal Relaxation, Stress Urinary Incontinence
Interventions: Votiva RF; Device
Lead sponsor: Walden, Jennifer L., M.D.,P.L.L.C.; Individual
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: New York, New York • Austin, Texas

Conditions: Chronic Migraine, Migraine Disorders, Headache Disorders, Headache, Migraine
Interventions: Osteopathic Manipulative Therapy (OMT), Standard of care; Procedure · Other
Lead sponsor: St. Luke's Hospital, Pennsylvania; Other
Eligibility: 18 Years to 50 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Bethlehem, Pennsylvania

Conditions: Pregnancy, Unplanned, Sexually Transmitted Diseases
Interventions: About Us; Behavioral
Lead sponsor: ETR Associates; Other
Eligibility: 14 Years to 18 Years
Enrollment: 550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Oakland, California • San Diego, California • Scotts Valley, California

Conditions: Breast Cancer, Pain, Prostate Cancer
Interventions: Observation, Educational Intervention and Behavioral Skills Training; Behavioral
Lead sponsor: Eastern Cooperative Oncology Group; Network
Eligibility: 18 Years to 120 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1998
U.S. locations: 15
States / cities: Urbana, Illinois • Cedar Rapids, Iowa • Des Moines, Iowa + 9 more

Conditions: Ventilator-Induced Lung Injury, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Preterm Infant
Interventions: Mid frequency ventilation, Standard frequency ventilation; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 3 Days
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Birmingham, Alabama • Mobile, Alabama

Conditions: Cutaneous Surgery
Interventions: Electrodesiccation and Curettage vs Excision; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Anxiety, Labor Pain, Nausea and Vomiting
Interventions: Aromatherapy plus standard of care, Standard of Care Only; Other
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 18 Years and older · Female only
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Autosomal Recessive Disorder, Aneuploidy
Interventions: Computer-Aided Genetic Education Module; Other
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Alzheimer's Dementia
Interventions: Resonator; Device
Lead sponsor: pico-tesla Magnetic Therapies, LLC; Industry
Eligibility: 55 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Endonasal Surgery, Endoscopic Sinus Surgery, Olfactory Dysfunction
Interventions: CONVIVO system, Fluorescein injection, USP 10%; Device · Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Sleep Disturbance, Trauma
Interventions: Melatonin 5mg and Sleep Education, Placebo; Dietary Supplement · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: COVID-19
Interventions: Thymalfasin; Drug
Lead sponsor: William B. Ershler, MD; Other
Eligibility: 18 Years and older
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chronic Posttraumatic Stress Disorder
Interventions: Revisiting the Trauma memories, Processing the trauma memories, Psychoeducation, Trauma Memory Retrieval Trial, Exposure to video clips related to the patient's trauma, Breathing retraining, Exposure Homework, Compound extinction; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Smoking, Smoking Cessation
Interventions: Tobacco Treatment; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 706 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Boston, Massachusetts

Search by objective public record fields.

Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations

Low-dose Buprenorphine Initiation for Opioid Use Disorder

Safety and Efficacy of RashEndZ Wound Aeration Technology

Inpatient Versus Outpatient Cervical Ripening

Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

Safety and Activity of F14 for Management of Pain Following Total Knee Replacement

Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy

Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation

Osteopathic Manipulative Treatment and Migraine Headaches

A Healthy Relationships Program for Vulnerable Youth

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome

Aesthetic Outcome of Electrodesiccation and Curettage vs Excision With Complex Linear Closure

Exploring the Effect of Aromatherapy

Prenatal Computer-Aided Genetics Education Module

Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease

In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients

Enhancing Exposure Therapy for Post-traumatic Stress Disorder

Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations